GeneOne Life Science, Inc. (011000.KS)
KRW 2035.0
(-3.1%)
KRW 2035.0
(-3.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 40.2 Billion | 48.71 Billion | 38.7 Billion | 41.5 Billion | 41.24 Billion | 34.29 Billion |
| Cost of Revenue | 55.18 Billion | 39.38 Billion | 29.94 Billion | 30.09 Billion | 28.35 Billion | 23.59 Billion |
| Gross Profit | -14.98 Billion | 9.33 Billion | 8.75 Billion | 11.41 Billion | 12.88 Billion | 10.69 Billion |
| Operating Expenses | 40.6 Billion | 49.41 Billion | 36.26 Billion | 29.87 Billion | 21.09 Billion | 21.95 Billion |
| Selling, General and Administrative Expenses | 26.34 Billion | 7.44 Billion | 3.79 Billion | 3.13 Billion | 1.89 Billion | 1.69 Billion |
| Research and Development Expenses | 7.04 Billion | 12.14 Billion | 11.44 Billion | 8.39 Billion | 5.87 Billion | 5.66 Billion |
| Other Expenses | 3.28 Billion | 29.82 Billion | 21.02 Billion | 18.34 Billion | 13.32 Billion | 3.85 Billion |
| Cost and Expenses | 88.57 Billion | 88.79 Billion | 66.2 Billion | 59.96 Billion | 49.45 Billion | 45.55 Billion |
| Operating Income | -48.36 Billion | -40.07 Billion | -27.5 Billion | -18.45 Billion | -8.2 Billion | -11.25 Billion |
| Interest Expense | 1.17 Billion | 7.3 Billion | 4.45 Billion | 628.49 Million | 1.96 Billion | 1.39 Billion |
| Income Tax Expense | 113.44 Million | 95.79 Million | 335.16 Million | 421.99 Million | 474.02 Million | 162.49 Million |
| Earnings before Tax | -77.65 Billion | -38.05 Billion | -15.61 Billion | -18.22 Billion | -7.14 Billion | -11.73 Billion |
| Net Income | -77.76 Billion | -38.15 Billion | -15.95 Billion | -18.64 Billion | -7.61 Billion | -11.89 Billion |
| Earnings Per Share Basic | -1000.23 | -492.35 | -214.86 | -258.90 | -212.16 | -301.98 |
| Earnings Per Share Diluted | -1000.23 | -492.35 | -214.86 | -258.90 | -212.16 | -294.41 |
| Weighted Average Shares Outstanding | 77.74 Million | 77.48 Million | 74.24 Million | 72.02 Million | 35.9 Million | 39.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 77.74 Million | 77.48 Million | 74.24 Million | 72.02 Million | 35.9 Million | 40.41 Million |
| Gross Margin | -0.37 | 0.19 | 0.23 | 0.27 | 0.31 | 0.31 |
| EBIT Margin | -1.58 | -0.54 | -0.29 | -0.35 | -0.04 | -0.16 |
| Profit Margin | -1.93 | -0.78 | -0.41 | -0.45 | -0.18 | -0.35 |
| EBITDA | -63.69 Billion | -25.32 Billion | -6.54 Billion | -13.63 Billion | -1.82 Billion | -9.05 Billion |
| Earnings Before Tax Margin | -1.20 | -0.82 | -0.71 | -0.44 | -0.20 | -0.33 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 9.29 Billion | 7.03 Billion | 40.2 Billion | 12.75 Billion | 11.72 Billion | 8.32 Billion |
| Cost of Revenue | 13.07 Billion | 11.04 Billion | 55.18 Billion | 15.51 Billion | 13 Billion | 12.23 Billion |
| Gross Profit | -3.78 Billion | -4.01 Billion | -14.98 Billion | -2.76 Billion | -1.27 Billion | -3.9 Billion |
| Operating Expenses | 7.9 Billion | 7.08 Billion | 33.38 Billion | 8.51 Billion | -10.55 Billion | 8.18 Billion |
| Selling, General and Administrative Expenses | 4.95 Billion | 6.47 Billion | - | 6.68 Billion | 10.55 Billion | 8.18 Billion |
| Research and Development Expenses | 2.94 Billion | 615.47 Million | - | 1.82 Billion | 1.68 Billion | 1.37 Billion |
| Other Expenses | -9.68 Billion | 1.24 Billion | 3.28 Billion | 4.62 Billion | -21.1 Billion | -1.38 Billion |
| Cost and Expenses | 20.98 Billion | 18.13 Billion | 88.57 Billion | 24.03 Billion | 13 Billion | 12.23 Billion |
| Operating Income | -11.69 Billion | -11.09 Billion | -48.36 Billion | -11.27 Billion | -11.82 Billion | -12.09 Billion |
| Interest Expense | 589.9 Million | 114.47 Million | 1.17 Billion | 263.86 Million | 73.43 Million | 146.67 Million |
| Income Tax Expense | 13.22 Million | 68.2 Million | 113.44 Million | 100.39 Million | 54 Thousand | 195 Thousand |
| Earnings before Tax | -12.79 Billion | -9.41 Billion | -77.65 Billion | -39.7 Billion | -11.55 Billion | -13.19 Billion |
| Net Income | -12.8 Billion | -9.48 Billion | -77.76 Billion | -39.8 Billion | -11.55 Billion | -13.19 Billion |
| Earnings Per Share Basic | -160.41 | -121.06 | - | -508.55 | -148.85 | -170.19 |
| Earnings Per Share Diluted | -160.41 | -121.06 | - | -508.55 | -148.85 | -170.19 |
| Weighted Average Shares Outstanding | 79.82 Million | 78.31 Million | 77.74 Million | 78.26 Million | 77.64 Million | 77.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 79.82 Million | 78.31 Million | 77.74 Million | 78.26 Million | 77.64 Million | 77.54 Million |
| Gross Margin | -0.41 | -0.57 | -0.37 | -0.22 | -0.11 | -0.47 |
| EBIT Margin | -0.79 | -0.94 | - | -0.56 | -0.11 | -0.47 |
| Profit Margin | -1.38 | -1.35 | -1.93 | -3.12 | -0.99 | -1.58 |
| EBITDA | -7.36 Billion | -6.61 Billion | - | -7.14 Billion | -1.27 Billion | -3.9 Billion |
| Earnings Before Tax Margin | -1.26 | -1.58 | -1.20 | -0.88 | -1.01 | -1.45 |
SRGHFL
004800
CIG
MAMO
ALCO
REH